Some GLP-1 receptor agonists, like Tirzepatide, have been shown to reduce the risk of major cardiovascular events (e.g., heart attack, stroke) in people with Type 2 diabetes and existing heart disease
Ongoing monitoring and follow-up should include regular re-assessment of dietary intake and hydration, for example, using food logs and/or food photos, and re-assessment of nutrient levels, using clinically accepted methodologies, during therapy to identify and promptly address emerging deficiencies
The primary endpoints were the change in body weight and the proportions of patients losing at least 5% and 10% of their initial body weight
The Future of Diabetes Care with GLP-1 RAs The landscape of diabetes care continues to evolve, and GLP-1 RAs are at the forefront of this transformation
They are commonly used by individuals with obesity or weight-related health conditions
11 Is there really a natural GLP-1